US Stock MarketDetailed Quotes

SILO Silo Pharma

Watchlist
  • 0.7487
  • -0.0613-7.57%
Trading Apr 30 11:20 ET
3.36MMarket Cap-0.63P/E (TTM)

Silo Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Assets
Current assets
Cash, cash equivalents and short term investments
-7.63%7.08M
-7.63%7.08M
-8.62%8.02M
-23.82%7.61M
-36.87%6.74M
-32.58%7.67M
-32.58%7.67M
-28.87%8.77M
12.89%9.99M
13.51%10.68M
-Cash and cash equivalents
10.82%3.91M
10.82%3.91M
2,332.40%4.86M
2,737.15%4.51M
-42.81%2.67M
-69.00%3.52M
-69.00%3.52M
-98.37%199.84K
-98.18%158.83K
-48.54%4.67M
-Short-term investments
-23.33%3.17M
-23.33%3.17M
-63.20%3.15M
-68.44%3.1M
-32.26%4.08M
132,705.64%4.14M
132,705.64%4.14M
10,897.38%8.57M
8,597.42%9.83M
1,649.51%6.02M
Receivables
----
----
----
----
--0
----
----
--69.6K
--68.39K
--67.19K
-Notes receivable
----
----
----
----
--0
----
----
--69.6K
--68.39K
--60K
-Accrued interest receivable
----
----
----
----
----
----
----
----
----
--7.19K
Other current assets
93.84%30.96K
93.84%30.96K
208.42%246.45K
-0.86%120.29K
-34.54%133.76K
-88.25%15.97K
-88.25%15.97K
-86.26%79.91K
21.41%121.33K
-1.02%204.35K
Total current assets
-7.42%7.11M
-7.42%7.11M
-7.39%8.26M
-24.06%7.73M
-37.21%6.88M
-33.62%7.68M
-33.62%7.68M
-30.91%8.92M
13.75%10.18M
13.89%10.95M
Non current assets
Goodwill and other intangible assets
--241.22K
--241.22K
--244.31K
--247.4K
----
--0
--0
----
----
----
-Other intangible assets
--241.22K
--241.22K
--244.31K
--247.4K
----
----
----
----
----
----
Other non current assets
-8.98%59.15K
-8.98%59.15K
-8.79%60.6K
-8.60%62.06K
-8.42%63.52K
-8.24%64.98K
-8.24%64.98K
--66.44K
--67.9K
--69.36K
Total non current assets
362.21%300.36K
362.21%300.36K
358.91%304.91K
355.75%309.46K
-8.42%63.52K
-8.24%64.98K
-8.24%64.98K
-51.53%66.44K
-30.24%67.9K
-28.93%69.36K
Total assets
-4.32%7.41M
-4.32%7.41M
-4.68%8.57M
-21.54%8.04M
-37.03%6.94M
-33.47%7.75M
-33.47%7.75M
-31.13%8.99M
13.28%10.25M
13.46%11.02M
Liabilities
Current liabilities
Payables
----
----
----
----
----
----
----
----
432.72%1.05M
199.25%660.28K
-accounts payable
----
----
----
----
----
----
----
----
572.18%1.05M
323.78%660.28K
Current deferred liabilities
0.00%72.1K
0.00%72.1K
0.00%72.1K
0.00%72.1K
0.00%72.1K
0.00%72.1K
0.00%72.1K
0.00%72.1K
0.00%72.1K
0.00%72.1K
Current liabilities
113.51%1.66M
113.51%1.66M
53.93%1.04M
18.09%1.32M
19.29%873.67K
77.76%775.59K
77.76%775.59K
117.42%678.77K
316.67%1.12M
150.17%732.38K
Non current liabilities
Non current deferred liabilities
-9.08%721.58K
-9.08%721.58K
-8.88%739.6K
-8.69%757.63K
-8.51%775.65K
-8.33%793.68K
-8.33%793.68K
-8.16%811.71K
-8.00%829.73K
-7.84%847.76K
Total non current liabilities
-9.08%721.58K
-9.08%721.58K
-8.88%739.6K
-8.69%757.63K
-8.51%775.65K
-8.33%793.68K
-8.33%793.68K
-8.16%811.71K
-8.00%829.73K
-7.84%847.76K
Total liabilities
51.51%2.38M
51.51%2.38M
19.72%1.78M
6.70%2.08M
4.38%1.65M
20.52%1.57M
20.52%1.57M
24.62%1.49M
66.56%1.95M
30.31%1.58M
Shareholders'equity
Share capital
42.09%449
42.09%449
44.37%449
31.19%408
0.00%316
0.00%316
0.00%316
-0.96%311
-96.87%311
-96.82%316
-common stock
42.09%449
42.09%449
44.37%449
31.19%408
0.00%316
0.00%316
0.00%316
-0.96%311
-96.87%311
-96.82%316
-Preferred stock
----
----
----
----
----
----
----
--0
--0
--0
Retained earnings
-40.41%-15.26M
-40.41%-15.26M
-38.80%-13.53M
-38.66%-12.61M
-44.52%-11.67M
-51.61%-10.87M
-51.61%-10.87M
-77.02%-9.75M
-100.89%-9.09M
-108.90%-8.08M
Paid-in capital
15.81%20.3M
15.81%20.3M
16.62%20.3M
10.30%19.2M
0.06%17.53M
0.08%17.53M
0.08%17.53M
0.28%17.41M
40.49%17.41M
41.14%17.52M
Less: Treasury stock
--0
--0
-96.13%6.27K
3,876.51%644.23K
--586.57K
--471.12K
--471.12K
--161.94K
--16.2K
----
Gains losses not affecting retained earnings
138.85%2.42K
138.85%2.42K
2,838.17%19.8K
344.62%8.03K
398.26%26.1K
---6.23K
---6.23K
---723
---3.28K
--5.24K
Total stockholders'equity
-18.50%5.03M
-18.50%5.03M
-9.53%6.78M
-28.18%5.96M
-43.96%5.29M
-40.27%6.18M
-40.27%6.18M
-36.76%7.5M
5.35%8.3M
11.06%9.44M
Total equity
-18.50%5.03M
-18.50%5.03M
-9.53%6.78M
-28.18%5.96M
-43.96%5.29M
-40.27%6.18M
-40.27%6.18M
-36.76%7.5M
5.35%8.3M
11.06%9.44M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Assets
Current assets
Cash, cash equivalents and short term investments -7.63%7.08M-7.63%7.08M-8.62%8.02M-23.82%7.61M-36.87%6.74M-32.58%7.67M-32.58%7.67M-28.87%8.77M12.89%9.99M13.51%10.68M
-Cash and cash equivalents 10.82%3.91M10.82%3.91M2,332.40%4.86M2,737.15%4.51M-42.81%2.67M-69.00%3.52M-69.00%3.52M-98.37%199.84K-98.18%158.83K-48.54%4.67M
-Short-term investments -23.33%3.17M-23.33%3.17M-63.20%3.15M-68.44%3.1M-32.26%4.08M132,705.64%4.14M132,705.64%4.14M10,897.38%8.57M8,597.42%9.83M1,649.51%6.02M
Receivables ------------------0----------69.6K--68.39K--67.19K
-Notes receivable ------------------0----------69.6K--68.39K--60K
-Accrued interest receivable --------------------------------------7.19K
Other current assets 93.84%30.96K93.84%30.96K208.42%246.45K-0.86%120.29K-34.54%133.76K-88.25%15.97K-88.25%15.97K-86.26%79.91K21.41%121.33K-1.02%204.35K
Total current assets -7.42%7.11M-7.42%7.11M-7.39%8.26M-24.06%7.73M-37.21%6.88M-33.62%7.68M-33.62%7.68M-30.91%8.92M13.75%10.18M13.89%10.95M
Non current assets
Goodwill and other intangible assets --241.22K--241.22K--244.31K--247.4K------0--0------------
-Other intangible assets --241.22K--241.22K--244.31K--247.4K------------------------
Other non current assets -8.98%59.15K-8.98%59.15K-8.79%60.6K-8.60%62.06K-8.42%63.52K-8.24%64.98K-8.24%64.98K--66.44K--67.9K--69.36K
Total non current assets 362.21%300.36K362.21%300.36K358.91%304.91K355.75%309.46K-8.42%63.52K-8.24%64.98K-8.24%64.98K-51.53%66.44K-30.24%67.9K-28.93%69.36K
Total assets -4.32%7.41M-4.32%7.41M-4.68%8.57M-21.54%8.04M-37.03%6.94M-33.47%7.75M-33.47%7.75M-31.13%8.99M13.28%10.25M13.46%11.02M
Liabilities
Current liabilities
Payables --------------------------------432.72%1.05M199.25%660.28K
-accounts payable --------------------------------572.18%1.05M323.78%660.28K
Current deferred liabilities 0.00%72.1K0.00%72.1K0.00%72.1K0.00%72.1K0.00%72.1K0.00%72.1K0.00%72.1K0.00%72.1K0.00%72.1K0.00%72.1K
Current liabilities 113.51%1.66M113.51%1.66M53.93%1.04M18.09%1.32M19.29%873.67K77.76%775.59K77.76%775.59K117.42%678.77K316.67%1.12M150.17%732.38K
Non current liabilities
Non current deferred liabilities -9.08%721.58K-9.08%721.58K-8.88%739.6K-8.69%757.63K-8.51%775.65K-8.33%793.68K-8.33%793.68K-8.16%811.71K-8.00%829.73K-7.84%847.76K
Total non current liabilities -9.08%721.58K-9.08%721.58K-8.88%739.6K-8.69%757.63K-8.51%775.65K-8.33%793.68K-8.33%793.68K-8.16%811.71K-8.00%829.73K-7.84%847.76K
Total liabilities 51.51%2.38M51.51%2.38M19.72%1.78M6.70%2.08M4.38%1.65M20.52%1.57M20.52%1.57M24.62%1.49M66.56%1.95M30.31%1.58M
Shareholders'equity
Share capital 42.09%44942.09%44944.37%44931.19%4080.00%3160.00%3160.00%316-0.96%311-96.87%311-96.82%316
-common stock 42.09%44942.09%44944.37%44931.19%4080.00%3160.00%3160.00%316-0.96%311-96.87%311-96.82%316
-Preferred stock ------------------------------0--0--0
Retained earnings -40.41%-15.26M-40.41%-15.26M-38.80%-13.53M-38.66%-12.61M-44.52%-11.67M-51.61%-10.87M-51.61%-10.87M-77.02%-9.75M-100.89%-9.09M-108.90%-8.08M
Paid-in capital 15.81%20.3M15.81%20.3M16.62%20.3M10.30%19.2M0.06%17.53M0.08%17.53M0.08%17.53M0.28%17.41M40.49%17.41M41.14%17.52M
Less: Treasury stock --0--0-96.13%6.27K3,876.51%644.23K--586.57K--471.12K--471.12K--161.94K--16.2K----
Gains losses not affecting retained earnings 138.85%2.42K138.85%2.42K2,838.17%19.8K344.62%8.03K398.26%26.1K---6.23K---6.23K---723---3.28K--5.24K
Total stockholders'equity -18.50%5.03M-18.50%5.03M-9.53%6.78M-28.18%5.96M-43.96%5.29M-40.27%6.18M-40.27%6.18M-36.76%7.5M5.35%8.3M11.06%9.44M
Total equity -18.50%5.03M-18.50%5.03M-9.53%6.78M-28.18%5.96M-43.96%5.29M-40.27%6.18M-40.27%6.18M-36.76%7.5M5.35%8.3M11.06%9.44M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Market Insights

Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Meritage Homes
MTH
67.210
KB Home
KBH
53.390
D.R. Horton
DHI
125.030
4
Strategy
MSTR
381.530
5
Lennar Corp
LEN
107.550
Log In for the Full List
Unlock Now

Investment Course

Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

Discussing

Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
MicroStrategy Q4 2024 earnings conference call

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.